§ 15–850
Statutes in effect as of October 1, 2026.
Md. Code Ann., Ins. § 15-850 (2026)
Title 15. Health Insurance
Subtitle 8. Required Health Insurance Benefits
§ 15–850LinkCopy Citation
(a)
In this section, “opioid antagonist” means:
(1)
naloxone hydrochloride; or
(2)
any other similarly acting and equally safe drug approved by the federal Food and Drug Administration for the treatment of a drug overdose.
(b)
(1)
This section applies to:
(i)
insurers and nonprofit health service plans that provide coverage for prescription drugs under individual, group, or blanket health insurance policies or contracts that are issued or delivered in the State; and
(ii)
health maintenance organizations that provide coverage for prescription drugs under individual or group contracts that are issued or delivered in the State.
(2)
An insurer, a nonprofit health service plan, or a health maintenance organization that provides coverage for prescription drugs through a pharmacy benefits manager is subject to the requirements of this section.
(c)
An entity subject to this section that includes on its formulary an opioid antagonist may apply a prior authorization requirement for an opioid antagonist only if the entity provides coverage for at least one formulation of the opioid antagonist without a prior authorization requirement.